iShares Neuroscience and Healthcare ETF (IBRN) Holdings → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free IBRN Stock Alerts $24.26 +0.22 (+0.92%) (As of 05/7/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Top 50 IBRN HoldingsRankCompanyCurrent PriceWeightShares Held1CERECerevel Therapeutics$42.26-0.6%4.92%4,0162NBIXNeurocrine Biosciences$143.19+1.0%4.84%1,2553ITCIIntra-Cellular Therapies$71.21+0.3%4.83%2,3064AXNXAxonics$67.38-0.3%4.74%2,4345ARGXargenx$398.81+1.3%4.37%4196SRPTSarepta Therapeutics$136.04+0.7%4.34%1,281 Get the Latest News and Ratings for IBRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. 7IARTIntegra LifeSciences$25.08+8.4%4.21%4,5808BIIBBiogen$218.92-1.1%4.13%7469XENEXenon Pharmaceuticals$43.43+0.6%4.12%3,51910BHVNBiohaven$41.49+0.7%4.08%3,32711ALKSAlkermes$24.59+2.0%3.77%5,45112PTCTPTC Therapeutics$31.79-3.5%3.70%5,15913SK Biopharmaceuticals Co Ltd Ordinary SharesN/A3.59%2,02214ACADACADIA Pharmaceuticals$17.25+1.5%3.41%6,86515CPRXCatalyst Pharmaceuticals$15.14+1.0%3.22%7,21516SUPNSupernus Pharmaceuticals$31.15+2.4%3.17%3,77817AVDLAvadel Pharmaceuticals$18.18-2.4%3.08%6,09018Neuren Pharmaceuticals LtdN/A2.94%8,04619H. Lundbeck AS Ordinary Shares - Class BN/A2.62%19,41020PRTAProthena$23.54-0.8%2.00%3,35221DYNDyne Therapeutics$25.65-2.3%1.97%2,86922EWTXEdgewise Therapeutics$21.23+4.4%1.95%4,33523SAVACassava Sciences$21.83+1.4%1.74%2,83024SRRKScholar Rock$14.69-2.5%1.58%3,90525BioArctic AB Class BN/A1.44%2,81626LBPHLongboard Pharmaceuticals$22.05+7.0%1.22%2,33727NMRANeumora Therapeutics$9.81+4.9%1.04%3,38528NVRONevro$11.53+3.4%0.91%2,53429WVEWave Life Sciences$5.79+0.7%0.86%6,19330ALECAlector$5.30-0.4%0.75%5,08831DNTHDianthus Therapeutics$24.04+0.5%0.69%1,00132VYGRVoyager Therapeutics$8.77-1.9%0.68%3,09133KYTXKyverna Therapeutics$13.65-2.2%0.66%1,18734AVXLAnavex Life Sciences$3.840.63%5,74635PEPGPepGen$13.96+0.1%0.61%1,76736ANNXAnnexon$4.73-1.7%0.58%4,45937SLDBSolid Biosciences$10.42+4.2%0.58%2,16338VNDAVanda Pharmaceuticals$5.48+13.2%0.57%3,93039AXGNAxoGen$5.83+2.8%0.56%2,93040ANROAlto Neuroscience$15.01+5.0%0.51%1,308The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read41TRDAEntrada Therapeutics$13.88+2.8%0.45%1,30442MicroPort NeuroTech LtdN/A0.41%13,00043Cellivery Therapeutics Inc Ordinary SharesN/A0.38%3,56544ABEOAbeona Therapeutics$4.56-4.6%0.37%1,68545LRMRLarimar Therapeutics$8.13-1.3%0.35%1,86746CVRXCVRx$8.10+1.6%0.32%71747NPCENeuroPace$13.30-1.3%0.32%78848CAPRCapricor Therapeutics$5.46-1.3%0.30%2,03049ABOSAcumen Pharmaceuticals$3.36-5.6%0.28%2,99850Newron Pharmaceuticals SpAN/A0.25%1,187 Geographic ExposureUnited States70.4%Ireland8.9%Canada4.2%Korea, Republic of3.9%Virgin Islands, British3.7%New Zealand2.9%Denmark2.6%Sweden1.4%Singapore1.0%Cayman Islands0.4%Italy0.3%Currency ExposureUSD88.4%KRW3.9%AUD2.9%DKK2.6%SEK1.4%HKD0.4%CHF0.3%Sector ExposureHealth Care62.5%Consumer Discretionary4.5%Industry ExposureBiotechnology54.5%Diversified Consumer Services4.5%Health Care Equipment & Supplies4.1%Pharmaceuticals3.9%SubIndustry ExposureBiotechnology47.5%Pharmaceuticals5.7%Health Care Equipment3.7%Health Care Supplies0.5%Coupon Exposure0-2100.0% Related Companies and Tools Related Companies: SENT Holdings UCYB Holdings NVIR Holdings KLNE Holdings NEWZ Holdings ETEC Holdings SKYU Holdings GLIF Holdings KEM Holdings BMED Holdings This page (NYSEARCA:IBRN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe AI Stock that’s Disrupting Every IndustryStockEarnings[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
